Inventor · disambiguated record
Jing-Hui Tian
Also filed as: TIAN JING · TIAN JING-HUI
27 granted patents·13 pending applications·305 citations·filing 1991–2025
96Inventor score
Top patents by PatentIndex Score
40 records- 0199US10953089B1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2020·Granted Mar 23, 2021·99 cites·20 claims
- 0298US11541112B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Jan 3, 2023·5 cites·20 claims
- 0396US11896664B2Corona virus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Feb 13, 2024·2 cites·34 claims
- 0496US11253586B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Granted Feb 22, 2022·4 cites·26 claims
- 0596US11253585B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2019·Granted Feb 22, 2022·8 cites·27 claims
- 0695US10426829B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2016·Granted Oct 1, 2019·17 cites·14 claims
- 0794US10357557B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2017·Granted Jul 23, 2019·13 cites·15 claims
- 0894US7897338B2Mobility-modified nucleobase polymers and methods of using sameAPPLIED BIOSYSTEMS LLC·Filed 2006·Granted Mar 1, 2011·17 cites·32 claims
- 0990US10821166B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2019·Granted Nov 3, 2020·3 cites·18 claims
- 1089US7074569B2Mobility-modified nucleobase polymers and methods of using sameAPPLERA CORP·Filed 2004·Granted Jul 11, 2006·20 cites·24 claims
- 1188US12491241B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2023·Granted Dec 9, 2025·0 cites·11 claims
- 1288US11364294B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2017·Granted Jun 21, 2022·2 cites·24 claims
- 1388US6743905B2Mobility-modified nucleobase polymers and methods of using sameAPPLERA CORP·Filed 2001·Granted Jun 1, 2004·24 cites·57 claims
- 1487US11478540B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2021·Granted Oct 25, 2022·1 cites·12 claims
- 1586US11278612B2Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2019·Granted Mar 22, 2022·3 cites·20 claims
- 1685US12472246B2Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Granted Nov 18, 2025·0 cites·12 claims
- 1784US5741855ACompatibilized fluoroplastic blendsRAYCHEM CORP·Filed 1996·Granted Apr 21, 1998·58 cites·6 claims
- 1884US2025360191A1Isolated polypeptide of the toxin a and toxin b proteins of c. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2025·Application pending·0 cites
- 1983US12324831B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2022·Granted Jun 10, 2025·0 cites·19 claims
- 2082US12257297B2Vaccine compositions having improved stability and immunogenicityNOVAVAX INC·Filed 2022·Granted Mar 25, 2025·0 cites·30 claims
- 2182US11123419B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2018·Granted Sep 21, 2021·1 cites·22 claims
- 2280US12083228B2Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2018·Granted Sep 10, 2024·1 cites·18 claims
- 2380US9598472B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofELLINGSWORTH LARRY R·Filed 2011·Granted Mar 21, 2017·5 cites·8 claims
- 2477US2024423926A1Methods and compositions for treating respiratory diseaseNOVAVAX INC·Filed 2024·Application pending·0 cites
- 2575US2024293530A1Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2024·Application pending·0 cites
- 2673US11357844B2Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofVALNEVA AUSTRIA GMBH·Filed 2020·Granted Jun 14, 2022·0 cites·20 claims
- 2772US5120807APolymerization of pyrrole and its derivativesUNIV DREXEL·Filed 1991·Granted Jun 9, 1992·22 cites·36 claims
- 2872US2024239953A1Biodegradable films comprising polyhydroxyalkanoatesPROCTER & GAMBLE·Filed 2024·Application pending·0 cites
- 2970US11938179B2Methods and compositions for inducing immune responses against Clostridium difficileNOVAVAX INC·Filed 2021·Granted Mar 26, 2024·0 cites·20 claims
- 3070US11896662B2Multivalent influenza nanoparticle vaccinesNOVAVAX INC·Filed 2021·Granted Feb 13, 2024·0 cites·12 claims
- 3163US2022332765A1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Application pending·0 cites
- 3262US2025025549A1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2022·Application pending·0 cites
- 3361US2011160082A1Mobility-Modified Nucleobase Polymers and Methods of Using SameLIFE TECHNOLOGIES CORP·Filed 2011·Application pending·0 cites
- 3457US2024392130A1Electrostatic dissipative polyamide composition and article comprising itSOLVAY SPECIALTY POLYMERS USA·Filed 2021·Application pending·0 cites
- 3556US9611462B2Endoglucanase 1B (EG1B) variantsCODEXIS INC·Filed 2012·Granted Apr 4, 2017·0 cites·13 claims
- 3656US2022354944A1Coronavirus and influenza compositions and methods for using themNOVAVAX INC·Filed 2022·Application pending·0 cites
- 3756US2023070886A1Coronavirus vaccine formulationsNOVAVAX INC·Filed 2021·Application pending·0 cites
- 3853US2004138415A1Helicobacter proteins, nucleic acids and uses thereofFiled 2001·Application pending·0 cites
- 3949US2002107368A1Helicobacter proteins, gene sequences and uses thereofFiled 2000·Application pending·0 cites
- 4041US2017354729A1Vaccine compositions containing modified zika virus antigensNOVAVAX INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing-Hui Tian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →